Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
16(47%)
Results Posted
0%(0 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_3
1
3%
Ph not_applicable
12
35%
Ph phase_4
1
3%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution14 total trials
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

13 of 16 finished

Non-Completion Rate

18.8%

3 ended early

Currently Active

16

trials recruiting

Total Trials

34

all time

Status Distribution
Active(18)
Completed(13)
Terminated(3)

Detailed Status

Completed13
Active, not recruiting8
Recruiting8
Not yet recruiting2
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
16
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (7.1%)
Phase 41 (7.1%)
N/A12 (85.7%)

Trials by Status

terminated13%
not_yet_recruiting26%
completed1338%
active_not_recruiting824%
withdrawn26%
recruiting824%

Recent Activity

16 active trials
Showing 5 of 34
completednot_applicable

Defining the Severe Paediatric Asthma Endotype

NCT04680117
recruiting

Rutgers University Study of the Genetics of Kidney Disease

NCT07217535
not_yet_recruitingnot_applicable

Dysbiosis of Methanogenic Archaea and Nanoarchaea in the Oral Microbiome

NCT07521644
active_not_recruiting

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

NCT05928416
completed

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

NCT04578509
View all 34 trials

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT04680117Not Applicable

Defining the Severe Paediatric Asthma Endotype

Completed
NCT07217535

Rutgers University Study of the Genetics of Kidney Disease

Recruiting
NCT07521644Not Applicable

Dysbiosis of Methanogenic Archaea and Nanoarchaea in the Oral Microbiome

Not Yet Recruiting
NCT05928416

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

Active Not Recruiting
NCT04578509

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

Completed
NCT06021548

Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach

Active Not Recruiting
NCT06995040Not Applicable

BREMISS : Brain Resilience Minor Stroke Study

Recruiting
NCT06787261Not Applicable

Involvement of Archaea in Carious Disease

Recruiting
NCT06764992

Exploring Men s Prostate Cancer Genetic Risk Perceptions

Completed
NCT04355533Not Applicable

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

Completed
NCT02530177

Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer

Active Not Recruiting
NCT03315910Phase 4

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Active Not Recruiting
NCT04872075Not Applicable

Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event

Completed
NCT07217522

Rutgers University Study of the Genetics of Pulmonary Hypertension

Recruiting
NCT06773897

Rutgers University Study of the Genetics of Breast Cancer.

Recruiting
NCT04860453

Genomic Analysis of Families With a History of Discordant Cancers

Recruiting
NCT07111936Not Applicable

Evaluating the Impact of CONNECT in a Multilingual Population

Not Yet Recruiting
NCT07119749Not Applicable

Vegan Whey Protein for Muscle Anabolism and Post-exercise Recovery

Completed
NCT03317964

Genetic Basis of Pacing-induced Cardiomyopathy

Completed
NCT03207594

Improving Evidence-Based Care for Cancer Patients

Completed

Drug Details

Intervention Type
OTHER
Total Trials
34